Q1 2025 for the BANK of Greenland With a profit before tax of DKK 39.1 million for Q1, the BANK of Greenland made a sound start to 2025. As expected, the result is affected by the declining level of ...

Interim Management Statement covering Q3 2024/25 The Board of Directors of Rovsing A/S has today reviewed and approved the ...

Interim Management Statement covering Q3 2024/25 The Board of Directors of Rovsing A/S has today reviewed and approved the Interim Management Statement for the third quarter (1 January 2025- 31 March ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...

ABU DHABI – Agility Global PLC, a multi-business owner and operator and long-term investor, today reported Q1 2025 earnings ...

In the REAL8 basket trial, Sogroya (somapacitan), administered as a once-weekly subcutaneous injection, was at least as ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

No. 11 / 2025 Zealand Pharma Announces Financial Results for the First Three Months of 2025Significant progress in the clinical pipeline, strengthening of organizational capabilities, and strategic ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

HHS Secretary Robert F. Kennedy Jr. and biopharmas will negotiate drug prices individually. Kennedy could "propose a rulemaking plan to impose MFN pricing" if no “significant” progress has been made.

Even though Danes are having historically few children these years, our population is increasing. One of the reasons is that ...